Schedule 13G ownership disclosure

ZIOPHARM ONCOLOGY INC

Security class unavailable · CUSIP: 98973P101

Event date: 2021-09-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,787,879
Percent of class
1.7300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001085146-21-002718
Form type
SC 13G/A
Filer
MILLER VALUE PARTNERS, LLC
CIK
CIK 1135778
Filed
Oct 12, 2021
Reporting period
Sep 30, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub